The joint statement comes after Bharat Biotech MD Dr Krishna Ella hit out at Serum CEO Adar Poonawalla’s comment that only Pfizer, Moderna, Oxford vaccines were effective.
In episode 653 of ‘Cut The Clutter’, the first in the new year, ThePrint’s Editor-in-Chief Shekhar Gupta explained working of Covaxin, Covishield & Zydus Cadila’s DNA vaccine.
The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.
Bharat Biotech MD Dr Krishna Ella says they gave ‘excellent safety data tested on around 25,000 participants’ & their efficacy data will be available by February-March.
Milind Deora joins Shashi Tharoor and Jairam Ramesh in questioning ‘premature approval’ for Bharat Biotech’s Covaxin even though the Congress has officially welcomed the vaccine.
The Serum Institute of India CEO said Covishield will be sold to the govt and Global Alliance for Vaccines and Immunization countries first and on the private market later.
India, which makes more than 60% of the world’s vaccines, risking transparency with its hasty vaccine approval will directly affect drug pricing and global acceptance.
Samajwadi Party chief Akhilesh Yadav erred big time with his ‘BJP’s vaccine’ comment. But it highlights how BJP is winning the battle of public perception in Covid management.
Indian judiciary has a corrosive imbalance between the bar and the bench. Those who supervise the district judiciary do so without the lived experience that is essential for meaningful reform.
With the US-India trade deal yet to get done, rupee depreciation may be helping to mitigate India’s loss of competitiveness. The other problem is extreme despondence among overseas equity investors.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
If you consider that the change of mind of SEC between 1st and 2nd Jan is questionable, perhaps, you should rope in some expert virologists and seek their views. I think, the head line seeks to sensationalise the matter as if the vaccine manufacturer did something irregular to get the view expressed on 1st reversed on 2nd. I read the minutes. They don’t seem to suggest any irregularity. Anyway, Covaxin is going to be a stand by to Covishield.
The author seems to be ready lot into nothing. Obviously funded by overseas pharma drug companies. If Print allows such articles who will pay for its journalism forget even reading it free
Both dcgi and icmr are Fraudulent bodies acting as per whims of modi.
If you consider that the change of mind of SEC between 1st and 2nd Jan is questionable, perhaps, you should rope in some expert virologists and seek their views. I think, the head line seeks to sensationalise the matter as if the vaccine manufacturer did something irregular to get the view expressed on 1st reversed on 2nd. I read the minutes. They don’t seem to suggest any irregularity. Anyway, Covaxin is going to be a stand by to Covishield.
*Loads of money* is how Bharat Biotech changed expert panel’s mind on Covaxin in a day and got approval.
The DGCA just give approval after getting order from PMO. The day not too far we become like N KOREA.
The author seems to be ready lot into nothing. Obviously funded by overseas pharma drug companies. If Print allows such articles who will pay for its journalism forget even reading it free